The mean values of the parameters of anemia, iron status, microinflammation, nutritional status, secondary hyperparathyroidism, and hypervolemia, depending on the use of short-acting and long-acting EPO, are shown in Tables 3 and 4. The gene discussed is EPO; the disease is Hypervolemia.